#Latest news with #HKStockMarketBloomberg21-05-2025BusinessBloombergHengrui Pharma Prices at Top End for $1.3 Billion Hong Kong ListingJiangsu Hengrui Pharmaceuticals Co. priced its Hong Kong stock offering at the top of the marketed range to raise HK$9.9 billion ($1.3 billion). The Chinese drugmaker, which focuses its research on cancer and cardiovascular diseases, sold 224.5 million shares at HK$44.05 a share, according to terms of the deal seen by Bloomberg.
Bloomberg21-05-2025BusinessBloombergHengrui Pharma Prices at Top End for $1.3 Billion Hong Kong ListingJiangsu Hengrui Pharmaceuticals Co. priced its Hong Kong stock offering at the top of the marketed range to raise HK$9.9 billion ($1.3 billion). The Chinese drugmaker, which focuses its research on cancer and cardiovascular diseases, sold 224.5 million shares at HK$44.05 a share, according to terms of the deal seen by Bloomberg.
21-05-2025
